CAHON Members

CAHON Connect September 2026 Newsletter

Message from the President and Chair of Board

Dear CAHON Members and Friends,

We are delighted to welcome you to the September 2026 issue of CAHON Connect. As we begin the 2026–2028 leadership term, we are inspired by the energy, engagement, and sense of community across CAHON.

This issue reflects many of the qualities that make CAHON special. We celebrate the extraordinary achievements and service of our members and friends, including our 2026 Lifetime Achievement and Outstanding Service Award recipients. We also recognize the accomplishments of our members, welcome new colleagues to the CAHON community, and highlight the important work underway across our committees.

We are also pleased to introduce two new newsletter features. Member Spotlight, led by the Public Relations Committee, will help us get to know the people behind CAHON, their professional journeys, contributions, and perspectives, and strengthen connections across our community. New FDA Approvals, developed by the Clinical Research Committee, will provide timely updates on important regulatory developments and emerging therapies that may influence oncology practice and patient care. Together, these additions reflect our commitment to making CAHON Connect both a stronger community forum and a valuable professional resource.

Looking ahead, one of our highest priorities is to continue creating opportunities for scientific exchange, professional development, mentorship, and collaboration. From our educational programs and New York Oncology Forum to our Young Investigator and Junior Investigator Awards and the new NextGen Summit, we remain committed to supporting the next generation of physicians, scientists, and leaders in hematology and oncology.

None of this would be possible without the dedication of our committee chairs and members, volunteers, our dedicated administrative leadership and staff, partners, and the many individuals who generously contribute their time and expertise to CAHON. We thank each of you for helping us build an increasingly vibrant, inclusive, and impactful professional community.

We look forward to working together during the coming term and to seeing many of you at our upcoming programs and events.

 

With warm regards,

Cynthia X. Ma, MD, PhD
President, CAHON

Lei Zheng, MD, PhD
Chair, CAHON Board of Directors

Chinese American Hematologist and Oncologist Network (CAHON)

Featured News

CAHON Honors Dr. Ronald Levy with Its 2026 Lifetime Achievement Award

The Lifetime Achievement Award recognizes individuals whose achievements have transformed the fields of hematology and oncology and whose enduring contributions have advanced the mission and growth of CAHON.


Ronald Levy, MD
Robert K. and Helen K. Summy Professor in the School of Medicine
Stanford University

Dr. Levy is internationally recognized as a pioneer of cancer immunotherapy whose groundbreaking work helped transform the treatment of cancer. His contributions to the development of monoclonal antibody therapies, including rituximab, have changed the lives of millions of patients worldwide and continue to shape the future of hematology and oncology.

In addition to his extraordinary scientific accomplishments, Dr. Levy has been a longtime friend and supporter of CAHON. Since attending our inaugural reception in 2005, he has generously contributed to our community as a keynote speaker, educator, mentor, and advocate, inspiring generations of hematologists and oncologists.

Dr. Levy will deliver the keynote address and be honored at the CAHON Dinner and Awards Banquet on Saturday, October 3, 2026, held in conjunction with the 13th Annual New York Oncology Forum at the Sheraton LaGuardia East in Flushing, New York.

CAHON Honors Dr. Liang Deng & Dr. Peter Q. Jiang with Its 2026 Outstanding Service Award

The Outstanding Service Award recognizes individuals who have made exceptional contributions to CAHON through their leadership, service, and dedication to advancing the organization's mission.


Liang Deng, MD, PhD
Associate Attending Physician and Associate Member
Memorial Sloan Kettering Cancer Center

During her tenure as President-Elect and President, Dr. Deng provided visionary leadership at a pivotal time in CAHON's growth. Her efforts to advance the organization's strategic plan led to numerous accomplishments, including the launch of the CAHON newsletter and monthly webinar series, growth in membership, and improvements to the membership application process.

Through her dedication, leadership, and unwavering commitment to CAHON, Dr. Deng strengthened our organization, expanded opportunities for members, and helped foster a more connected and engaged professional community. Her lasting contributions exemplify the spirit of the Outstanding Service Award.

Read more about Dr. Deng in the Member Spotlight below.


Peter Q. Jiang, MD, PhD
Medical Oncologist and Hematologist
John B. Amos Cancer Center

Since 2019, Dr. Jiang has generously volunteered his time and talents as CAHON's unofficial event photographer, helping to document and preserve the history of our organization. Through his dedicated service on the Public Relations Committee and his presence at nearly every in-person CAHON event, he has captured the people, moments, and milestones that define our community.

His photographs reflect not only the activities and achievements of CAHON, but also the warmth, camaraderie, and sense of family that bring our members together. Through his work, countless members have seen their accomplishments recognized, friendships celebrated, and memories preserved. His dedication has left a lasting imprint on CAHON and enriched the member experience in ways that extend far beyond the images themselves.

Dr. Deng and Dr. Jiang will be honored at the CAHON Dinner and Awards Banquet on Saturday, October 3, 2026, held in conjunction with the 13th Annual New York Oncology Forum at the Sheraton LaGuardia East in Flushing, New York.

Read more about Dr. Jiang in the Member Spotlight below.

Membership Spotlight & Community News

Member Spotlight


Liang Deng, MD, PhD
Associate Attending Physician and Associate Member
Memorial Sloan Kettering Cancer Center

1. Tell us briefly about your professional journey and what you focus on today.

I am a physician-scientist and dermatologist at Memorial Sloan Kettering Cancer Center, with a research program at The Rockefeller University. My clinical and research interests have always intersected around cancer, immunology, and viral infections. I care for patients with melanoma and virus-associated cancers, including Kaposi sarcoma and Merkel cell carcinoma, while my laboratory work focuses on developing virus-based cancer immunotherapies and understanding how innate immunity can be harnessed against cancer and infections. What continues to excite me is the opportunity to connect discoveries in the laboratory with meaningful advances for patients.

2. What brought you to CAHON, and what has kept you deeply involved over the years?

I was introduced to CAHON by Wenru Song, Ke Liu, and Jianda Yuan at a cancer immunology conference we were all attending. I became involved because I saw the value of bringing together Chinese American physicians and scientists working in hematology and oncology. But over time, CAHON became much more than a professional organization to me. It became a family.

Over the years I was invited to speak at the New York Oncology Forum and the China Cancer Immunotherapy Workshop several times, and later served as chair of the Career Development Committee before being elected President for the 2024–2026 term. What has kept me involved through all of it is the people. CAHON brings together individuals at different institutions, career stages, and areas of expertise who share a willingness to support one another. I am deeply honored to receive this year’s Outstanding Service Award, though I would say it belongs equally to the committee chairs and members, board members, and volunteers belongs equally to the committee chairs and members, board members, and volunteers who work tirelessly for our organization.

3. What is your vision for the future of CAHON?

I hope CAHON will continue to grow as a professional community with national and global impact, and our most important responsibility is to invest in the next generation. Programs like the Junior Investigator Award and the New York Oncology Forum are where that investment becomes visible, and I would like to see them expand. But mentorship cannot stop at recognition. My hope is that within a few years we see younger members not only presenting at our meetings but chairing our committees and setting the agenda.

I would also like to see CAHON become an even stronger platform for scientific collaboration, education, and professional development. There is extraordinary talent within our community, and there is far more we can accomplish collectively than any of us can individually. Ultimately, I hope we build a CAHON that remains strong and sustainable for generations to come while making meaningful contributions to cancer research, patient care, and our broader community.

4. What do you enjoy doing when you’re not working?

I have three passions outside of medicine and science: tennis, cooking, and music. Tennis keeps me active and competitive and is a wonderful way to clear my mind. Cooking gives me a different kind of satisfaction. I enjoy creating something with my hands and, even more importantly, sharing it with family and friends. Music has always been a source of enjoyment, energy, and reflection for me.

Interestingly, these interests have something in common with science and medicine: they all involve curiosity, practice, creativity, and the opportunity to keep learning and improving.

5. What is bringing you joy or inspiration these days?

Increasingly, I find joy and inspiration in discussing science and medicine with young people. Their curiosity, energy, and willingness to ask questions remind me why I chose this career in the first place.

I still get tremendous excitement from making a scientific discovery or seeing a patient benefit from a new treatment. But I have also discovered a different kind of fulfillment in helping a student, trainee, or young physician-scientist develop an idea, overcome an obstacle, or see possibilities they had not considered before.

That is also one reason I care so deeply about CAHON’s future. Perhaps one of the most meaningful things we can accomplish is to help the next generation go further than we have.


Peter Q. Jiang, MD, PhD
Medical Oncologist and Hematologist
John B. Amos Cancer Center

1. You have been practicing hematology and oncology for more than 20 years. What first drew you to oncology?

Twenty years ago, I chose oncology because I believed, and I still believe, that oncology is the best field in medicine.

What has made the career especially meaningful is the relationship with my patients. I have always tried to treat every patient as I would treat a member of my own family. To be recognized by my patients and colleagues over the years has meant a great deal to me.

After 20 years, I still feel fortunate to do this work.

2. You knew about CAHON as early as fellowship, but your relationship with the organization developed later. What changed?

I knew about CAHON when I was a fellow, but honestly, I did not pay much attention to it in the beginning.

It took me another 10 years to realize: CAHON is a big family for Chinese American oncologists.

That became increasingly important to me. Through CAHON, we have a network of colleagues and friends, opportunities for academic development, and people we can call for advice about difficult patient-care questions. But it is more than a professional network. There is also friendship and personal enrichment.

Over time, I realized that this community was something very special.

3.What does receiving the CAHON Outstanding Service Award mean to you?

I am very honored. Service has always been part of how I think about being a physician.

In my local community, I have supported our annual breast cancer symposium and participated in Cancer Survivors Day and other community activities. Oncology does not end when the patient leaves the clinic. We care for patients, but we also support families, survivors, and the community around them.

The same is true of CAHON. We help each other so that, ultimately, we can take better care of our patients.

4. Many people in CAHON know you as the person behind the camera. How did photography become part of your life?

I like taking photos because I want to preserve the moments of our happiness and our achievements. And if you want better photos, you have to learn how to take better photos. So I learned photography from YouTube.

For me, the photographs are not only about photography. Years later, we can look back and remember the people, the meetings, the trips, and the happy moments we shared together.

5. When you put away the stethoscope, and occasionally the camera, what does Dr. Jiang enjoy outside of medicine?

I enjoy watching almost every sport, although I have realized that watching sports does not count as exercise! So now I am trying to increase my activity level. Like many of my CAHON friends, I have started playing pickleball.

My goal is to become part of the “healthy old generation.”

I am also a longtime fan of playing cards. In fact, when I was in Shanghai, I earned my wife through playing cards!

I would say that was probably my best win.

And I am still a big fan of playing cards today.

Members Making an Impact

Mark Lee, MD, PhD

Published Article in the  Journal of Clinical Oncology

CAHON congratulates Mark Lee, an Allied Member from N-Power Medicine, Inc., on the recent publication of a Journal of Clinical Oncology (JCO) article co-authored alongside distinguished leaders in oncology, including former FDA Commissioner Dr. Stephen Hahn, former NCI Director Dr. Ned Sharpless, and Dr. Mark Socinski of AdventHealth Research Institute. The publication introduces the concept of Prospective External Control Arms (ProECAs), an innovative approach with the potential to significantly accelerate oncology drug development. Through this work, N-Power is seeking partnerships with biotechnology and pharmaceutical companies, as well as academic and community cancer centers, to advance the generation and application of ProECAs. CAHON is proud to recognize Mark's contributions and celebrates this important advancement in the field.

If you are interested in becoming a partner, click here.

Luyuan Li, MD, PhD

Recent Publications, Feature, and an Award Recipient

CAHON congratulates Dr. Luyuan Li, Associate Member and PGY-2 Internal Medicine Resident at North Alabama Medical Center, on a series of notable academic achievements. In August 2026, Dr. Li published "Chondrosarcoma: A Comprehensive Review of Tumor Biology, Clinical Behavior, and Therapeutic Advances" as first author in Cancer Treatment Reviews. The publication was subsequently featured by OncoDaily, recognizing the significance of this contribution to the field.

In addition, Dr. Li was selected to receive an AACR Scholar-in-Training Award, supported by the NCI Center to Reduce Cancer Health Disparities, and will present research on mortality trends in malignant bone and articular cartilage neoplasms at the 19th AACR Conference on The Science of Cancer Health Disparities this October. Earlier this year, Dr. Li also published "Advances in Radiation Therapy for Primary Bone Malignancies" as first author in Technology in Cancer Research & Treatment. CAHON is proud to recognize Dr. Li's dedication to advancing cancer research and improving outcomes for patients.

Dan Qi, PhD

Mentee Earns Prestigious NIH/NCI Award

Lifetime Member Dr. Erxi Wu of Baylor Scott & White Health is pleased to share that his mentee, Dr. Dan Qi, has been awarded an NIH/NCI K22 Career Transition Award to support her research in cancer diagnosis. This significant achievement highlights Dr. Qi's potential as an emerging leader in cancer research and underscores the impact of dedicated mentorship. CAHON congratulates both Dr. Wu and Dr. Qi on this exciting milestone.

Tian Zhang, MD, MHS

Promoted to Professor of Internal Medicine

CAHON is pleased to recognize Dr. Tian Zhang, a Lifetime Member, on a recent promotion to Professor of Internal Medicine at UT Southwestern Medical Center, effective September 1, 2026. This achievement reflects dedication to advancing oncology care, research, and education. We congratulate Dr. Zhang on this well-deserved milestone and are proud to have her as part of the CAHON community.

Welcoming our New Members Since May 1st!

Associate

  • Yu-Han Chen - University of Texas MD Anderson Cancer Center
  • Justin M. Cheung, MD - Memorial Sloan Kettering Cancer Center
  • Ariel Galor - Jacobi Medical Center/AECOM
  • Nehemias A. Guevara Rodriguez, MD - St. Louis University
  • Yuhao Guo - Danbury Hospital
  • Heng Jiang - Westchester Medical Center
  • Tim Kong, MD, PhD - NewYork-Presbyterian Weill Cornell Medical Center
  • Katie Luc, MD - Maimonides Medical Center
  • Matteo Savelli - Jefferson Einstein Montgomery
  • Andrea Y. Sun - WashU Medicine Internal Medicine Residency Program
  • Reanna Wang - Jefferson Einstein Montgomery Hospital
  • Dongni Yi, MD - Mayo Clinic, Rochester, MN

Regular

  • Wen Wee Ma, MBBS - Cleveland Clinic
  • Yunan Nie, MD - Mass General Brigham Cancer Center
  • Eric T. Wong, MD, MA, FANA, FAAN - Brown University Health

Allied

  • Xiaozhong Liu, PhD - Worcester Polytechnic Institute

For more information on membership categories and to apply for membership, visit here.

New CAHON Membership Category - Honorary Lifetime Membership

CAHON is honored to recognize two accomplished leaders as Honorary Lifetime Members. These individuals have made important contributions to cancer research, clinical care, and scientific innovation, helping advance the field and improve outcomes for patients worldwide. We are pleased to welcome them to the CAHON community and look forward to engaging with them in the years ahead.

  • Tara Withington, CAE -  Since 2018, Tara has helped guide CAHON's transformation into a highly respected international professional society, bringing decades of leadership experience and best practices in nonprofit management to strengthen the organization's operations, governance, and long-term vision. Her partnership and dedication have been instrumental in positioning CAHON for continued success and impact within the global oncology community. Ms. Withington was recognized during the CAHON Summer Symposium and Reception on May 30th. 
     
  • Zhijian (James) Chen, PhD -  A world-renowned immunologist and Professor at UT Southwestern Medical Center, Dr. Chen's pioneering discoveries, including the cGAS-STING pathway, have fundamentally advanced our understanding of immune responses and opened new avenues for cancer immunotherapy. His scientific achievements have had a lasting impact on cancer research and patient care around the globe. Dr. Chen will be recognized and deliver a plenary talk during the upcoming New York Oncology Forum on October 3rd.

New FDA Approvals

The Clinical Research Committee continues to support CAHON members by tracking and compiling recent FDA approvals since May 2026. This growing resource highlights notable therapeutic advances, new indications, and other regulatory milestones that are helping to shape the future of oncology care. By bringing these updates together in one place, the committee provides members with an accessible overview of developments that may impact both clinical practice and patient outcomes. View the full list here.

Recent Events

Post-ASCO Virtual Update

The Post-ASCO 2026 Virtual Update took place on July 26th.The educational webinar featured prominent CAHON members leading cancer centers who highlighted key advances presented at the 2026 ASCO Annual Meeting. Through expert presentations on breast, thoracic, gastrointestinal (GI), genitourinary (GU), melanoma, sarcoma, and hematologic cancers, including lymphoma and chronic lymphocytic leukemia (CLL), the program provided attendees with timely insights into emerging research and its impact on oncology practice.

The event was recorded for CAHON Members, and can be accessed by logging into your account here.

Virtual Tumor Board

CAHON's Virtual Tumor Board Series continued in June with a session featuring challenging and educational case discussions led by CAHON members from leading institutions. Presentations addressed subsequent-line therapy for metastatic HER2-mutant anal adenocarcinoma, management of erythropoietin (EPO)-refractory anemia in end-stage renal disease, and metastatic synchronous colorectal cancer, fostering interdisciplinary learning and discussion on complex clinical scenarios.

The event was recorded for CAHON Members, and can be accessed by logging into your account here.

Quarterly Seminar Series | May

The Quarterly Seminar Series that took place on May 2, 2026 featured presentations from distinguished CAHON members and rising investigators on a range of clinical, research, and career development topics. Highlights included Dr. David Chang's reflections on his career journey from physician-scientist to private practice and investing, Dr. Chenyang Zhan's discussion of liver-directed therapies for metastatic uveal melanoma, and fellow presentations on novel therapeutic approaches in medulloblastoma and CAR-T therapy for multiple myeloma. The session showcased CAHON's commitment to advancing oncology education, mentorship, and academic collaboration across the cancer care community.

The event was recorded for CAHON Members, and can be accessed by logging into your account here.

Summer Symposium & Reception

The 2026 Summer Symposium & Reception took place in Chicago, IL at the Metropolitan in the Willis Tower on May 30th. T he evening featured two impactful scientific presentations on next-generation antibody-drug conjugates and novel immunotherapy targets within the "dark genome." CAHON also celebrated excellence through the Young Investigator Awards Ceremony and announced the recipients of the 2026 Honorary Lifetime Membership. The program concluded with closing remarks and the introduction of CAHON's incoming leadership team for the 2026-2028 term.

 View Events Photos

Upcoming Events

Read more: Upcoming in-person events and Upcoming virtual events

CAHON Awards

Since 2015, in addition to the Lifetime Achievement and Outstanding Service Awards, CAHON has been committed to identifying, recognizing, and supporting the next generation of leaders in hematology and oncology by providing recognition to promising physicians, researchers, trainees and student. These awards help cultivate future leaders whose research, innovation, and dedication will shape the future of cancer care and scientific discovery.

  • Young Investigator Awards (YIAs) - Offered in conjunction with selected national and international scientific meetings and CAHON educational programs, this award highlights the achievements of emerging investigators whose research contributes to improved patient care and advances in cancer research. CAHON will be offering YIAs for the upcoming CAHON meetings taking place during SITC, ASH and AACR. Read more about the 2026 Summer YIAs recipients below. 
     
  • Young Investigator Travel Awards (YITAs) - Designed to support the professional development and scholarly achievements of CAHON's early-career and physician-in-training members. Each year, CAHON provides travel awards to eligible members to attend the New York Oncology Forum (NYOF) and participate in educational, networking, and research opportunities. 
     
  • Junior Investigator Award (JIAs) - Encourage talented students with an interest in oncology research and the Asian American community to pursue scientific inquiry and academic excellence. Each year, CAHON provides awards to outstanding high school, college, and medical students to attend the New York Oncology Forum (NYOF), where they can engage with leading physicians, researchers, and healthcare professionals.

2026 Fall Symposium Young Investigator Awards - Call for Applications Open Now! Read more here.

Committee Corner

This past quarter marked the beginning of the CAHON Committees' 2026-2028 term. Building on the momentum of previous years, committee membership has grown substantially since the 2024-2026 term, reaching an all-time high number of volunteers eager to contribute and support CAHON's work.

Academic Committee

Hong Zheng, MD, PhD (Chair)
Ping Chi, MD, PhD (Co-Chair)
Li Chai, MD
Chi Lin, MD, PhD
Minggui Pan, MD, PhD
Jeffrey J. Pu, MD, PhD
Guang Yang, MD, PhD
Xiaolin Zhu, MD, PhD

The Academic Committee is happy to share the recipients of the 2026 Summer Symposium Young Investigator Awards (YIAs): 

  • Shijia Li, MD - Bridgeport Hospital
  • Xuanyi Li, MD - Yale Cancer Center
  • Yue Li, MD - Jacobi Medical Center
  • Janet Song, MD - Kaiser Permanente Northern California
  • Andrea Y Sun - WashU Internal Medicine Residency
  • Jingyao Zhang, MD - Danbury Hospital, Zucker School of Medicine at Hofstra/Northwell
  • Xianghui Zou, MD, PhD - New York University

506

The Academic Committee has been hard at work reviewing a record number of applications for the 2026 New York Oncology Forum Young Investigator Travel Awards (YITAs) and Junior Investigator Awards (JIAs). We look forward to announcing this year's recipients in the coming weeks.

Applications are now open for the Young Investigator Awards to be presented at the Fall Symposium during SITC, with submissions due by September 30, 2026. Learn more here.

The committee is also preparing to launch the application cycle for the Young Investigator Awards associated with the Winter Symposium during ASH, which will open later this month.

More information can be found here. 

Career Development Committee

Lei Deng, MD (Chair)
Mary Li, MD, PhD (Co-Chair)
Elizabeth Budde, MD, PhD
Haoran Li, MD, PhD
Emily Liang, MD
Hongtao Liu, MD, PhD
Chenyang Zhan, MD, PhD
Wenqing Zhang, MD, PhD

The Career Development Committee and the Event & Education Committee are co-hosting a Career Pathways Webinar on Sunday, September 27, 2026. With help from the Event and Education Committee, this webinar will bring together oncologists from academic, community, industry, and policy settings to discuss career paths available within hematology/oncology. Panelists will share insights on key decision points, mentorship, and the trade-offs that shape professional trajectories, along with common pitfalls and lessons learned. The session will conclude with an interactive Q&A. Read more here.

The Committee is also excited to introduce the NextGen Summit, a new in-person event coming to the West Coast in early 2027. Designed for trainees, early-career physicians, researchers, and industry partners, the Summit will feature scientific updates, career development programming, mentorship opportunities, and networking with leaders across hematology and oncology. More details coming soon!

If you are interested in signing up as a mentee or a mentor, please email info@cahon.org for more information.

Clinical Practice Committee

Shuang Fu, MD, PhD (Chair)
Joyce Huang, MD, PhD (Co-Chair)
Sunny Chai, MD, PhD
Gang Chen, MD, PhD
Kevin Han, MD
John Wei, MD
Jingyao Zhang, MD
Yue Zhang, MD, MPH

The Clinical Practice Committee is actively planning the upcoming Community Oncology Forum, which will be held in Boston, Massachusetts, in Spring 2027. Additional details will be shared in the coming months. They are also planning for a highly interactive series of case discussions during the 2026 NYOF.

Clinical Research Committee

Yucai Wang, MD, PhD (Chair)
Bo Wang, MD (Co-Chair)
Feng-Ming Spring Kong, MD, PhD
Wenying Liang, MD, PhD
Vincent T. Ma, MD
Xia (Yaya) Wu, MD
Fengting Yan, MD, PhD
Jingsong Zhang, MD, PhD

As part of its ongoing commitment to keeping members informed of key developments in oncology, the Clinical Research Committee has compiled a list of recent FDA approvals. This resource highlights important advancements in treatment options and patient care. View the full list here. Read more about these New FDA Approvals above.

Event and Education Committee 

Christine Ye, MD, MS (Chair)
Charles Jiang, MD, MPH (Co-Chair)
Can Cui, MD, PhD
Ronan Hsieh, MD, MS
Zhaohui Jin, MD
Zhengrui Xiao, MD
Xi Yang, MD

The Event & Education Committee helped organize the Post-ASCO Virtual Update, held on July 26. The educational webinar featured prominent CAHON members leading cancer centers who highlighted key advances presented at the 2026 ASCO Annual Meeting. Through expert presentations on breast, thoracic, gastrointestinal (GI), genitourinary (GU), melanoma, sarcoma, and hematologic cancers, including lymphoma and chronic lymphocytic leukemia (CLL), the program provided attendees with timely insights into emerging research and its impact on oncology practice.

For those who missed the Post-ASCO Update, it was recorded for CAHON Members, and can be accessed by logging into your account here.

The Event & Education Committee and the Career Development Committee are co-hosting a Career Pathways Webinar on Sunday, September 27, 2026. This webinar will bring together oncologists from academic, community, industry, and policy settings to discuss career paths available within hematology/oncology. Panelists will share insights on key decision points, mentorship, and the trade-offs that shape professional trajectories, along with common pitfalls and lessons learned. The session will conclude with an interactive Q&A. Read more here.

The Committee is also excited to introduce the NextGen Summit, a new in-person event coming to the West Coast in early 2027. Designed for trainees, early-career physicians, researchers, and industry partners, the Summit will feature scientific updates, career development programming, mentorship opportunities, and networking with leaders across hematology and oncology. More details coming soon!

Fellow Committee

Xiaocao (Haze) Xu, MD (Chair)
Tien-Chan Hsieh, MD (Co-Chair)
Simo Du, MD, MHS
Linjie Luo, MD, PhD
Qian Wang, MD, MPH
Yuqing Wang, MD, PhD
Jiazhang Xing, MD
Jiahe Zhao, MD
Kehua Zhou, MD

The Fellow Committee started its new term strong with an initial committee meeting, during which members established shared priorities and generated several promising ideas for future programs and collaborations. Already making progress toward these goals, the committee is planning a practical mentor-mentee program in collaboration with other committees. The initiative aims to create a structured and sustainable framework that effectively matches mentors and mentees based on their interests, career goals, and areas of expertise. In addition, the committee is developing ideas for upcoming webinars focused on mentorship, professional development, and topics relevant to fellow and trainee members.

Industry Committee 

Jianda Yuan, MD, PhD  (Chair)
Ke Liu, MD, PhD (Co-Chair)
Yong Ben, MD
Oliver Kong, MD
Mark Lee, MD, PhD
Yufeng Li, PhD
Yan Wang, PhD
Pan Zheng, MD, PhD

The Industry Committee remains dedicated to highlighting innovative developments that are shaping the future of oncology, particularly in the rapidly evolving field of artificial intelligence. In December 2025, the committee launched its AI-focused educational series with the highly attended AI in Healthcare: Development and Potential Applications webinar. Building on this momentum, the committee is continuing its commitment to exploring AI-driven advancements and their potential impact on patient care, research, and clinical practice. Stay tuned for more dynamic programming in the months ahead.

The webinar was recorded for CAHON Members, and can be accessed by logging into your account here.

Membership Committee

Yong Ji, MD, PhD (Chair)
Haixia Qin, MD, PhD (Co-Chair)
Jackson Gao, MD
Zach Liu, MD
Xuezhu (Sunny) Wang, MD
Meng Xu Welliver, MD, PhD
Deng Zhang, MD, PhD

The Membership Committee continues to strengthen and expand the CAHON community by welcoming new members from across the field. We are pleased to share that 16 individuals have joined CAHON over the past four months, reflecting the continued growth and impact of our organization. Learn more about these newest members above in the Membership Corner. 

Public Relations Committee 

Ligeng Tian, MD, PhD (Chair)
Faye Yin, MD, FACP (Co-Chair)
Hui Chen, MD
Peter Jiang, MD, PhD
Yating Wang, MD
Tiantian Zhang, MD, PhD
Yumeng Zhang, MD
Zhen Zhang, PharmD, BCOP, BCPS

The Public Relations Committee began its new term with a productive summer meeting focused on enhancing CAHON's communications and outreach efforts. Members discussed several exciting initiatives to strengthen the organization's social media presence, increase engagement with current and prospective members, and further highlight the accomplishments of the CAHON community. The committee is also exploring personalized outreach strategies to promote upcoming events and foster deeper connections among members and supporters.

NEW: Wellness Committee 

Jane Jijun Liu, MD (Chair)
David Chang, MD, PhD, FACP (Co-Chair)
Lijun Dai, MD, PhD
Xuan Huang, MD, PhD
Yongli Ji, MD, PhD
Chaoyang Li, MD
Wenru Song, MD, PhD
Weijing Sun, MD, PhD
Dan Zhao, MD, PhD

The Wellness Committee is CAHON's newest committee, dedicated to supporting the well-being of CAHON members. As part of its initial efforts, the committee launched a wellness assessment to better understand members' needs and identify opportunities for meaningful support. The results presented below reflect responses from CAHON members and provide valuable insights to help guide future wellness initiatives. Notably, the assessment identified Integrated Health, Movement & Physical Well-Being, and Social Connection & Fulfillment as key areas of interest and focus among respondents. This assessment remains ongoing, and members are encouraged to participate in the survey and share their perspectives.

You can submit your response here.

The Journal of Hematology & Oncology (JHO) - Official Journal of CAHON

The Journal of Hematology & Oncology provides a forum for top-quality research and is the leading title in hematology and oncology, with an Impact Factor ranked in Q1 in both categories. The journal also publishes reviews and research highlights from leading experts in the field. Research is shared with fast turnaround times in an open access format among laboratory scientists, physician scientists, hematologists and oncologists.

Prof Delong Liu, Editor-in-Chief
Journal of Hematology & Oncology

Impact factor 47.8!

Link to articles: https://jhoonline.biomedcentral.com/articles

CAHON Social Media

In October 2024, CAHON officially launched its X and LinkedIn accounts. Follow us for member highlights, updates, and more.

We also have an exclusive Members-Only WeChat group. To join, please send the following details to info@cahon.org.

  • Your WeChat ID (adjusted to reflect your professional name, affiliation or location, and specialty) 
  • A short introduction that includes your current role/position, and ALL prior education and work experience
  • Professional Photo
  • Chinese name (if applicable)

Please review our social media policy: Social Media Policy

We Need Your Support - Consider a Donation to CAHON

Easy Ways to Support:

  • Visit https://www.cahon.org to make a tax-deductible donation

  • Request a Corporate Match - Many companies will match a donation if you provide them with CAHON tax ID number

  • Include CAHON in your Donor-Advised Fund providing CAHON tax ID number 

Thank You to Our 2026 Corporate Partners!

Partnering for Progress: How Our Corporate Partners Are Powering Cancer Innovation

Agios is a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts. The company’s vision is to redefine the future of rare disease treatment. Fueled by connections, it builds trusted partnerships with communities – collaborating to develop and deliver innovative medicines that have the potential to transform lives. With a foundation in hematology, Agios combines biological expertise with real-world insights to advance a growing pipeline of rare disease medicines that reflect the priorities of the people it serves. To learn more, visit www.agios.com and follow Agios on LinkedIn and X. 

BeOne Medicines is a global oncology company discovering and developing innovative treatments for cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of novel therapeutics through its internal capabilities and collaborations. Our global team works across six continents, driven by scientific excellence and speed to reach more patients than ever. Learn more at https://beonemedicines.com/

Exelixis is a globally ambitious oncology company innovating next-generation medicines and regimens at the forefront of cancer care. Powered by drug discovery and development excellence, we are rapidly evolving our product portfolio to target an expanding range of tumor types and indications with our clinically differentiated pipeline of small molecules and biotherapeutics. or information about the company and its mission to help cancer patients recover stronger and live longer, visit www.exelixis.com, follow @ExelixisInc on X (Twitter), like Exelixis, Inc. on Facebook and follow Exelixis on LinkedIn.

Ipsen is a global biopharmaceutical company focused on innovation and specialty care. At Ipsen, we develop and commercialize medicines in three key therapeutic areas – Oncology, Neuroscience and Rare Disease. Our focus in oncology is on some of the most difficult-to-treat cancers. We have a portfolio of therapies for solid tumors and in hematology aimed at improving the lives of people living with pancreatic cancer, gastrointestinal and pancreatic neuroendocrine tumors, and carcinoid syndrome. Every day, our more than 5,000 employees worldwide, including nearly 800 in North America, work diligently to improve lives around the world. For more information, please visit www.ipsen.com/us.

Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/news, or follow us on Facebook, Instagram and LinkedIn.

Natera™ is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives. To learn more, visit https://www.natera.com/oncology/

Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Learn more about our commercialized and investigational products at https://www.rigel.com/pipeline

Thank You to Our 2026 Annual Oncology Supporters!

Cookie Notice

This website uses cookies to deliver to you the best experience possible on the CAHON website. By continuing to use this site, you are providing to us your consent to ensure you receive such an experience. View our privacy policy to learn more.

Accept